|
1
|
Lin L, Hutzen B, Zuo M, Ball S, Deangelis
S, et al: Novel STAT3 phosphorylation inhibitors exhibit potent
growth-suppressive activity in pancreatic and breast cancer cells.
Cancer Res. 70:2445–2454. 2010. View Article : Google Scholar
|
|
2
|
Hutzen B, Friedman L, Sobo M, Lin L, Cen
L, et al: Curcumin analogue GO-Y030 inhibits STAT3 activity and
cell growth in breast and pancreatic carcinomas. Int J Oncol.
35:867–872. 2009.PubMed/NCBI
|
|
3
|
Groner B, Lucks P and Borghouts C: The
function of Stat3 in tumor cells and their microenvironment. Semin
Cell Dev Biol. 19:341–350. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brantley EC and Benveniste EN: Signal
transducer and activator of transcription-3: a molecular hub for
signaling pathways in gliomas. Mol Cancer Res. 6:675–684. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yu H, Pardoll D and Jove R: STATs in
cancer inflammation and immunity: a leading role for STAT3. Nat Rev
Cancer. 9:798–809. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu A, Liu Y, Xu Z, Yu W, Wang H, et al:
Novel small molecule, XZH-5, inhibits constitutive and
interleukin-6-induced STAT3 phosphorylation in human
rhabdomyosarcoma cells. Cancer Sci. 102:1381–1387. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bromberg JF, Horvath CM, Besser D, Lathem
WW and Darnell JE Jr: Stat3 activation is required for cellular
transformation by v-src. Mol Cell Biol. 18:2553–2558.
1998.PubMed/NCBI
|
|
8
|
Schlessinger K and Levy DE: Malignant
transformation but not normal cell growth depends on signal
transducer and activator of transcription 3. Cancer Res.
65:5828–5834. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Inghirami G, Chiarle R, Simmons WJ, Piva
R, Schlessinger K and Levy DE: New and old functions of STAT3: a
pivotal target for individualized treatment of cancer. Cell Cycle.
4:1131–1133. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bromberg JF, Wrzeszczynska MH, Devgan G,
Zhao Y, Pestell RG, et al: Stat3 as an oncogene. Cell. 98:295–303.
1999. View Article : Google Scholar
|
|
11
|
Buettner R, Mora LB and Jove R: Activated
STAT signaling in human tumors provides novel molecular targets for
therapeutic intervention. Clin Cancer Res. 8:945–954.
2002.PubMed/NCBI
|
|
12
|
Turkson J and Jove R: STAT proteins: novel
molecular targets for cancer drug discovery. Oncogene.
19:6613–6626. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xiong H, Zhang ZG, Tian XQ, Sun DF, Liang
QC, et al: Inhibition of JAK1, 2/STAT3 signaling induces apoptosis,
cell cycle arrest, and reduces tumor cell invasion in colorectal
cancer cells. Neoplasia. 10:287–297. 2008.PubMed/NCBI
|
|
14
|
Tang J, Li HL, Shen YH, et al: Antitumor
and antiplatelet activity of alkaloids from veratrum
dahuricum. Phytother Res. 24:821–826. 2010.PubMed/NCBI
|
|
15
|
Ivanova A, Serly J, Christov V, et al:
Alkaloids derived from genus Veratrum and Peganum of
Mongolian origin as multidrug resistance inhibitors of cancer
cells. Fitoterapia. 82:570–575. 2011.
|
|
16
|
Tang J, Li HL, Shen YH, et al: Antitumor
activity of extracts and compounds from the rhizomes of Veratrum
dahuricum. Phytother Res. 22:1093–1096. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wittig R and Coy JF: The role of glucose
metabolism and glucose-associated signalling in cancer. Perspect
Medicin Chem. 1:64–82. 2007.PubMed/NCBI
|
|
18
|
Zhao J, Jiang P and Zhang W: Molecular
networks for the study of TCM Pharmacology. Brief Bioinform.
11:417–430. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gordaliza M: Natural products as leads to
anticancer drugs. Clin Transl Oncol. 9:767–776. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pon D, Wang Z, Le KN and Chow MS:
Harnessing traditional Chinese medicine to improve cancer therapy:
issues for future development. Ther Deliv. 1:335–344. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hsiao WL and Liu L: The role of
traditional Chinese herbal medicines in cancer therapy - from TCM
theory to mechanistic insights. Planta Med. 76:1118–1131. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen ZF and Liang H: Progresses in TCM
metal-based antitumour agents. Anticancer Agents Med Chem.
10:412–423. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Darnell JE Jr: STATs and gene regulation.
Science. 277:1630–1635. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zushi S, Shinomura Y, Kiyohara T, et al:
STAT3 mediates the survival signal in oncogenic ras-transfected
intestinal epithelial cells. Int J Cancer. 78:326–330. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Masuda M, Suzui M, Yasumatu R, et al:
Constitutive activation of signal transducers and activators of
transcription 3 correlates with cyclin D1 overexpression and may
provide a novel prognostic marker in head and neck squamous cell
carcinoma. Cancer Res. 62:3351–3355. 2002.
|
